Quantcast

Latest squamous cell carcinoma Stories

2014-05-06 08:36:28

Dr. Justin Piasecki, Washington Doctor and Mohs Surgery Expert, at Forefront of Skin Cancer GIG HARBOR, Wash., May 6, 2014 /PRNewswire/ -- Recognized as the most common cause of cancer in the United States, skin cancer accounts for approximately half of all the cancers in the country.[1] According to the Skin Cancer Foundation, more than 3.5 million cases of skin cancer are diagnosed each year, with the incidences of skin cancer outnumbering all cases of breast, colon, lung, and prostate...

2014-05-06 08:35:12

CheapCaribbean.com Recognizes Melanoma and Skin Cancer Awareness Month in May PLANO, Texas, May 6, 2014 /PRNewswire/ -- In recognition of Melanoma and Skin Cancer Awareness Month in May, the "Beach Vacation Experts" at CheapCaribbean.com have issued travel-focused tips for vacationers planning their summer beachside escapes. And while skin cancer is not the only danger of sun exposure - as ultraviolet (UV) rays can cause sunburns, wrinkles and damage to the eyes - it is one of the...

2014-04-22 08:33:00

BETHESDA, Md., April 22, 2014 /PRNewswire-USNewswire/ -- The rate of developing esophageal squamous cell carcinoma (ESCC) nearly doubles in those who both smoke and drink compared to those who only smoke or drink, according to new research published in The American Journal of Gastroenterology. Although multiple studies have identified risk factors for the development of ESCC, notably, exposure to alcohol and tobacco, this research is the first meta-analysis to look at the interaction...

2014-04-17 23:01:36

Zoll, Kranz & Borgess, LLC, (ZKB) a pharmaceutical and medical device litigation firm, is currently investigating claims of men who developed melanoma after taking the pharmaceutical drug, Viagra (sildenafil citrate), which is marketed by the US-based pharmaceutical company, Pfizer. Toledo, OH (PRWEB) April 17, 2014 Studies have suggested that sildenafil use may increase the invasiveness of melanoma cells, which may raise the possible adverse effect of melanoma. On April 7, 2014, a...

2014-04-15 08:29:16

Trial Will Evaluate Investigational Compound's Efficacy and Safety as an Addition to Standard Chemotherapy in Previously-Untreated Patients NORTH CHICAGO, Ill., April 15, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced the initiation of a global Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer (NSCLC). The trial...

2014-04-09 11:41:42

Results from the study could help determine potential treatment options A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers. In a study to be presented at the AACR Annual Meeting 2014 on Tuesday, April 8, Ranee Mehra, MD, a medical oncologist who specializes in head and neck cancers at Fox Chase Cancer Center, and colleagues, showed a...

2014-04-03 11:16:23

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers. The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein...

2014-03-31 23:25:26

New research report “NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the APAC NSCLC market is predicted to post a 6.3% CAGR to amount to USD 2.9 billion by 2019. London, UK (PRWEB) March 31, 2014 As for 2012, the non-small cell lung cancer (NSCLC) market in the APAC region was evaluated...

2014-03-28 23:04:53

Markets Research Reports.biz added deep and professional market research reports on "NSCLC Therapeutics In Asia-Pacific Markets To 2019 - Personalized Therapies Focus On Untapped Segment Of Squamous Cell Carcinoma To Expand Treatment Pool" Market Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis-details/nsclc-therapeutics-in-asia-pacific-markets-to-2019-personalized-therapies-focus-on-untapped-segment-of-squamous-cell-carcinoma-to-expand-treatment-pool....

2014-03-20 16:26:44

Public Can Get Free Screenings During Oral Head and Neck Cancer Awareness Week®, April 20-26 NEW YORK, March 20, 2014 /PRNewswire/ -- A first-of-its-kind study shows that sore throat and neck mass are the most common initial symptoms of a form of oral, head and neck cancer that is rapidly increasing in incidence, oropharyngeal squamous cell carcinoma (OPSCC). The study, published online March 20, 2014 in JAMA Otolaryngology - Head & Neck Surgery, cites sore throat as the most...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related